Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT00013468 · ClinicalTrials.gov registry record

Early Diagnosis of Steroid-Responsive & No-Responsive Hearing Loss

A clinical trial of Hearing Loss, sponsored by US Department of Veterans Affairs.

Completed
Registry status
50
Enrollment target
1
Study location

NCT00013468 is a study of Hearing Loss that has completed, run by US Department of Veterans Affairs. The registered enrollment target is 50 participants, below the 6,120-participant average among 58 other Hearing Loss trials with a reported enrollment target (99% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT00013468, a study of Hearing Loss, has completed, sponsored by US Department of Veterans Affairs.

COMPLETED
Registry status
50 participants
Enrollment target
1
Study location

Study Summary

Tinnitus is a prevalent issue for veterans who are proportionally more hearing-impaired than the civilian population. This study will be conducted as three concurrent projects designed to develop an efficient clinical technique to quantify tinnitus perception: (1)Laboratory development of the automated technique for comprehensive tinnitus quantification;(2)Development of a technique to test for tinnitus "malingering"; and (3)Evaluation of the automated technique in the clinical environment.

Conditions Studied

Interventions

  • PROCEDURE Tinnitus

Study Locations (1)

Oregon

  • VAMC, Portland - Portland

Trial Details

FieldValue
Enrollment Target 50 participants
Start Date 2000-08
Est. Completion 2003-08

Sponsor

US Department of Veterans Affairs

632 total trials

What the Registry Record Tells You About NCT00013468

The ClinicalTrials.gov registry entry for NCT00013468 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 50 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 6,120-participant average among 58 other Hearing Loss trials with a reported enrollment target (99% lower). The listed sponsor is US Department of Veterans Affairs, which has 632 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Hearing Loss appearing as the primary indexed condition, and to 1 intervention - of which Tinnitus is the first listed.

NCT00013468 reports 1 study location spanning 1 distinct geographic area - top geographies include Oregon.

Frequently Asked Questions

What is clinical trial NCT00013468 about?

NCT00013468 is a clinical study titled "Early Diagnosis of Steroid-Responsive & No-Responsive Hearing Loss". Tinnitus is a prevalent issue for veterans who are proportionally more hearing-impaired than the civilian population. This study will be conducted as three concurrent projects designed to develop an efficient clinical technique to quantify tinnitus perception: (1)Laboratory development of the auto...

What is the current status of trial NCT00013468?

This trial is currently completed. The enrollment target is 50 participants. The study started on 2000-08. Estimated completion is 2003-08.

What conditions does trial NCT00013468 study?

This clinical trial studies the following conditions: Hearing Loss.

What interventions are being tested in trial NCT00013468?

The interventions under investigation include: Tinnitus (PROCEDURE).

Who is sponsoring clinical trial NCT00013468?

This trial is sponsored by US Department of Veterans Affairs, which has 632 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT00013468 being conducted?

This trial has 1 study location across Oregon. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Hearing Loss

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.